What is the CVSS score of CVE-2022-1067?

CVE-2022-1067 has a CVSS 3.1 base score of 6.5 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N. EPSS exploitation probability: 0.9%.

Patient Portal CVE-2022-1067

MEDIUM

Authentication Bypass Using an Alternate Path or Channel (CWE-288)

2022-04-11 ics-cert@hq.dhs.gov

Information Disclosure Patient Portal

6.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

6.5 MEDIUM

AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

None

Availability

None

Lifecycle Timeline

CVE Published

Apr 11, 2022 - 20:15 nvd

MEDIUM 6.5

DescriptionNVD

Navigating to a specific URL with a patient ID number will result in the server generating a PDF of a lab report without authentication and rate limiting.

AnalysisAI

Navigating to a specific URL with a patient ID number will result in the server generating a PDF of a lab report without authentication and rate limiting. Rated medium severity (CVSS 6.5), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-288. Navigating to a specific URL with a patient ID number will result in the server generating a PDF of a lab report without authentication and rate limiting. Affected products include: Lifepoint Patient Portal.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.